Powerking Soft Capsule

Adult dose

For adults: 1 capsule once a day

This drug should not be taken in doses exceeding 5,000 IU per day by women in the first three months of pregnancy or those who may become pregnant due to the risk of congenital malformations from excessive vitamin A intake. Patients with hypercalcemia, sarcoidosis (an unknown cause systemic inflammatory disease), or kidney disease should not take this drug. Individuals with allergic reactions to any component in this drug, infants under three months, kidney stone patients, and those allergic to soybean oil, beans, or peanuts should also avoid taking it. Those receiving medical treatment, patients with oxalosis, pregnant or breastfeeding women, premature infants, patients with a history of gout or kidney stones, lipid metabolism disorders, and individuals sensitive to Tartrazine Yellow No. 4 and Yellow No. 5 should consult a specialist before taking this. If symptoms such as nausea, vomiting, itching, dry skin, painful joint swelling, or diarrhea occur during use, discontinue immediately and consult a specialist. Long-term high-dose use may lead to tolerance and pose risks of peptic ulcers, glucose intolerance, hyperuricemia, and liver damage, so caution is needed. Women post-menopause should be cautious with long-term high doses of vitamin A, as it may increase the risk of osteoporosis. Dosage should strictly adhere to prescribed instructions, and since vitamin A is adequately obtained from food, the supplemental dosage should not exceed 5,000 IU per day. This drug may affect blood glucose measurements during urine tests and can change urine color to yellow, affecting clinical test results. Patients with lipid metabolism issues or at risk of lipid overload should regularly monitor plasma lipid levels and adjust dosages if necessary. Keep out of reach of children and store in a sealed container in a cool, dry place away from direct sunlight. To maintain quality, do not transfer to another container and take precautions against misuse.

Mild side effects

• Nausea
• vomiting
• itching
• dry and rough skin
• painful joint swelling
• diarrhea
• loose stools
• development of tolerance
• exacerbation of peptic ulcers
• glucose intolerance

Drug interactions

This drug should be used with intravenous lipid preparations only after consultation with a physician or pharmacist.

This drug should be stored in a sealed container that can block light, preferably at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and ensure its safe use.

Appearance

Dark green oblong soft capsule containing yellowish-brown contents

Package unit

1 capsule/pack, 600 capsules/box [(1 capsule/pack x 600)]